Skip to main content
. 2016 May 25;20(9):1611–1619. doi: 10.1111/jcmm.12852

Figure 1.

Figure 1

miR‐224 increased the sensitivity of MG‐63 cells to cisplatin. (A) miR‐224 expression was measured in osteosarcoma cell lines (MG‐63, U2OS, SOSP‐9607 and SAOS‐2) and hFOB cells by qRT‐PCR. (B) miR‐224 expression in MG‐63 cells transfected with a miR‐224 mimic was determined by qRT‐PCR. (C) Cell survival was evaluated using MTS assays. *P < 0.05, **P < 0.01 and ***P < 0.001.